On 12 January, a press release was issued on ‘Confirmation of efficacy of cultured supernatant therapy using deciduous stem cells for amyotrophic lateral sclerosis (ALS)’.
Three months have since passed, and the publication and press release have far exceeded our expectations. We will report on what has happened since then in this column.
For more information, please see Column: Topics.
Conditioned Medium Therapy for ALS – The first in human report and its aftermath